Retrospective Evaluation of the Application of Dutasteride, Unapproved by the FDA, for Male Pattern Baldness in Korea
September 2015
in “
한국임상약학회지
”
Studysummary In this study, both the topical minoxidil 7%/dutasteride 0.5 mg and topical minoxidil 7%/finasteride 1 mg treatments for androgenetic alopecia showed high effectiveness, but the dutasteride combination was associated with greater efficacy and more adverse effects.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on kmbase.medric.or.kr →